Manfred Hauben
Public Health and Preventive Medicine
400 E 71st St Apt 16C
New York, NY 10021
New York, NY 10021
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Correction: The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.
Journal: Drug safety
Published: July 27, 2026
Artificial Intelligence in Pharmacovigilance: Guiding Principles from the CIOMS Working Group XIV.
Journal: Drug safety
Published: May 17, 2026
The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.
Journal: Drug safety
Published: April 10, 2026
Verbal Expressions of Probability in Pharmacovigilance: Most Likely Too Ambiguous.
Journal: Clinical therapeutics
Published: March 23, 2026
When does Follow-up on Adverse Events Improve the Understanding of Medicine and Vaccine Safety? Insights from Global Expert Perspectives.
Journal: Drug safety
Published: March 14, 2026
A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.
Journal: Drug safety
Published: December 04, 2025
How LLMs can advance safety case intake-points to consider and insights from a proof of concept.
Journal: Therapeutic advances in drug safety
Published: October 29, 2024
The evolving role of disproportionality analysis in pharmacovigilance.
Journal: Expert opinion on drug safety
Published: June 24, 2024
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
Journal: Drug safety
Published: March 07, 2024
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.
Journal: Drug safety
Published: March 07, 2024
Last Updated: 09/26/2026